Jun 2017 – Aug 2019 · 2 yrs 2 mos · New Delhi Area, India

Jun 2016 – Jul 2016 · 1 mo · Japan

• National Institute of Genetics, Japan hosts the DNA data bank of Japan and conducts ground-breaking research leveraging novel
• genetic tools and elaborate supercomputing infrastructure to study the progression of genetically modified disorders.
• Accelerated the pioneering work on decoding the molecular pathogenesis of orphan diseases using recently developed 3C
• principles with high-throughput genomic sequencing technology.
• Performed unbiased genome-wide screening for identification and validation of genetic makeup interacting with disease specific
• target molecules while constructing 3C DNA libraries.
• Employed exhaustive computational techniques to analyse RNA-seq data and identify differentially expressed genes, deduce
• biological pathways underlying the prognosis of endometriosis.
• Only intern offered “Project Associate” position to lead research in the field of endometriosis.

Aug 2015 – May 2017 · 1 yr 9 mos · Chennai Area, India

• Diabetes is a debilitating chronic disorder with high global prevalence and leading cause of death. Identifying and validating potential
• drug targets for such a metabolic disorder can be a path-breaking discovery for the pharmaceutical industry.
• Screened the largest database, dbSNP for short genetic variations in anti-insulin peptide, pancreastatin to find lead molecules for
• potential drug targets.
• Genetically engineered insulin receptor in yeast expression system to achieve 100-fold synthesis. Studied its differential interaction
• with identified gain-of-function variants using comprehensive bioinformatics tools.
• Validated the computational findings for an enhanced anti-insulin activity exhibited by a functional variant using in-vitro techniques.